Harnessing microRNA biology to treat
    cardiovascular and muscle disease
Friday January 27, 2012

about us

miRagen Therapeutics was founded in 2007 to improve patients’ lives by developing innovative microRNA (miRNA) based therapeutics for the treatment of cardiovascular and muscle disease. miRNAs, a recently discovered class of small RNAs encoded in the genome ... [more]

 
quick links
  areas of focus   mission and vision   careers  
  Even with our current understanding of molecular mechanisms, cardiovascular disease (CVD) remains the primary cause of morbidity and mortality in the industrialized ... [more]   miRagen believes that through cooperation and teamwork we can make a difference. Together, we created our mission and vision statements to reflect our commitment to you. ... [more]   At miRagen, our staff members have a true passion for innovative science. We believe that hiring the brightest, most talented individuals will help us fulfill our mission to create breakthrough ... [more]